Mary Tagliaferri - Apr 27, 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role: Director
Signature: /s/ Mary Tagliaferri
Stock symbol: ENZ
Transactions as of: Apr 27, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/29/2022, 04:44 PM
Next filing: Jul 14, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENZ	Common Stock, $0.01 Par Value	Award	$0	+39.1K		$0.00	39.1K	Apr 27, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ENZ	Stock Option (to acquire Common Stock)						77.1K	Apr 27, 2022	Common Stock	77.1K	$2.63	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted Restricted Stock Units that will vest, subject to the individual continuing to serve as a member of the board of directors of Enzo Biochem, Inc., in two equal annual instalments, beginning on April 27, 2023.
F2	The stock options have a five-year term. Fifty percent of the stock options have vested, and the remaining fifty percent will vest on January 11, 2023.